000 | 01950 a2200541 4500 | ||
---|---|---|---|
005 | 20250513214055.0 | ||
264 | 0 | _c20001211 | |
008 | 200012s 0 0 eng d | ||
022 | _a0340-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGawaz, M | |
245 | 0 | 0 |
_aIncomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cJun 2000 |
||
300 |
_a915-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAbciximab |
650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 |
_aAngina Pectoris _xblood |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
650 | 0 | 4 |
_aBlood Platelets _xchemistry |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadministration & dosage |
650 | 0 | 4 |
_aMembrane Glycoproteins _xdrug effects |
650 | 0 | 4 | _aMicroscopy, Electron |
650 | 0 | 4 |
_aP-Selectin _xdrug effects |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aReceptors, Thrombin _xchemistry |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aRuf, A | |
700 | 1 | _aPogatsa-Murray, G | |
700 | 1 | _aDickfeld, T | |
700 | 1 | _aRüdiger, S | |
700 | 1 | _aTaubitz, W | |
700 | 1 | _aFischer, J | |
700 | 1 | _aMüller, I | |
700 | 1 | _aMeier, D | |
700 | 1 | _aPatscheke, H | |
700 | 1 | _aSchömig, A | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 83 _gno. 6 _gp. 915-22 |
|
999 |
_c10846632 _d10846632 |